FOXP3+lymphocyte density in pancreatic cancer correlates with lymph node metastasis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Jiang, Yongjian ^a   Du, Zunguo ^a   Yang, Feng ^a   Di, Yang ^a   Li, Ji ^a   Zhou, Zhongwen ^a   Pillarisetty, Venu G ^b   Fu, Deliang ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOXP3+ LYMPHOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MALE; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; RISK FACTOR; CELL COUNT; CYTOLOGY; IMMUNOLOGY; LYMPH NODE; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; REGULATORY T LYMPHOCYTE; YOUNG ADULT;

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; AGED; CELL COUNT; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84906997513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106741     Document Type: Article

References (22)

1. Nentwich MF, Bockhorn M, König A, Izbicki JR, Cataldegirmen G (2012) Surgery for advanced and metastatic pancreatic cancer-current state and trends. Anticancer Res 32: 1999-2002.
2. Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, et al. (2012) The pancreas cancer microenvironment. Clin Cancer Res 18: 4266-4276.
3. Wachsmann MB, Pop LM, Vitetta ES (2012) Pancreatic ductal adenocarcinoma: a review of immunologic aspects. J Investig Med 60: 643-663.
4. Chen M-L, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, et al. (2005) Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Pro Natl Acad Sci USA 102: 419-424.
5. Yuan X-L, Chen L, Li M-X, Dong P, Xue J, et al. (2010) Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 134: 277-288.
6. Azuma T, Takahashi T, Kunisato A, Kitamura T, Hirai H (2003) Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res 63: 4516-4520.
7. Liang B, Workman C, Lee J, Chew C, Dale BM, et al. (2008) Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 180: 5916-5926.
8. Liyanage UK, Moore TT, Joo H-G, Tanaka Y, Herrmann V, et al. (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169: 2756-2761.
9. Ikemoto T, Yamaguchi T, Morine Y, Imura S, Soejima Y, et al. (2006) Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas 33: 386-390.
10. Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions. Clin Cancer Res 12: 5423-5434.
11. Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, et al. (2013) Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 108: 914-923.
12. Tang Y, Xu X, Guo S, Zhang C, Tang Y, et al. (2014) An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma. PLoS ONE 9: e91551.
13. Shibuya KC, Goel VK, Xiong W, Sham JG, Pollack SM, et al. (2014) Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment. PLoS ONE 9: e96565.
14. Kondo S (2010) Japanese Pancreas Society Staging Systems for Pancreatic Cancer. Pancreatic Cancer. New York, NY: Springer New York. pp. 1035-1050.
15. Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, et al. (2009) Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas 38: e13-e17.
16. Sakai M, Nakao A, Kaneko T, Takeda S, Inoue S, et al. (2005) Para-aortic lymph node metastasis in carcinoma of the head of the pancreas. Surgery 137: 606-611.
17. Massucco P, Ribero D, Sgotto E, Mellano A, Muratore A, et al. (2009) Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers. Ann Surg Oncol 16: 3323-3332.
18. Fujita T, Nakagohri T, Gotohda N, Takahashi S, Konishi M, et al. (2010) Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas 39: e48-e54.
19. Swartz MA, Lund AW (2012) Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 12: 210-219.
20. Deng L, Zhang H, Luan Y, Zhang J, Xing Q, et al. (2010) Accumulation of Foxp3+ T Regulatory Cells in Draining Lymph Nodes Correlates with Disease Progression and Immune Suppression in Colorectal Cancer Patients. Clin Cancer Res 16: 4105-4112.
21. Huang Y, Liao H, Zhang Y, Yuan R, Wang F, et al. (2014) Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis. PLoS ONE 9: e94376.
22. Obong AE, Clear AJ, Watt J, Wang J, Fatah R, et al. (2013) Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma. Gastroenterology 145: 1121-1132.